<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02380807</url>
  </required_header>
  <id_info>
    <org_study_id>UAL- 423</org_study_id>
    <nct_id>NCT02380807</nct_id>
  </id_info>
  <brief_title>Effects of Dry Needling on Spinal Mobility and Trigger Points in Patients With Fibromyalgia Syndrome.</brief_title>
  <official_title>Effects of Dry Needling on Posture, Spinal Mobility and Trigger Points on Spinal Muscles in Patients With Fibromyalgia Syndrome.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Universidad de Almeria</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Universidad de Almeria</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study evaluates the effect of Dry Needling on Spinal Mobility and Trigger Points in
      Patients with Fibromyalgia Syndrome.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Dry Needling is a skilled intervention that uses a thin filiform needle to penetrate the skin
      and stimulate underlying myofascial trigger points, muscular, and connective tissues for the
      management of neuromusculoskeletal pain and movement impairments. Dry needling (DN) is a
      technique used to treat dysfunctions in skeletal muscle, fascia, and connective tissue, and,
      diminish persistent peripheral nociceptive input, and reduce or restore impairments of body
      structure and function leading to improved activity and participation.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>March 2015</start_date>
  <completion_date type="Actual">July 2015</completion_date>
  <primary_completion_date type="Actual">March 2015</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Pain Intensity</measure>
    <time_frame>up to Four Weeks</time_frame>
    <description>A 10-point Numerical Pain Scale (0: no pain, 10: maximum pain) assesses the intensity of pain.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Number of participants with Trigger Points</measure>
    <time_frame>up to Four Weeks</time_frame>
    <description>Dry Needly Therapy will be assesses in trigger points on trapezius muscle, supraspinatus muscle, infraspinatus muscle, latissimus dorsi, iliocostalis muscle, multifidus muscles, and quadratus lumbourum muscle.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Posture and Spinal Mobility</measure>
    <time_frame>up to Four Weeks</time_frame>
    <description>Spinal Mouse is a device that, combined with a computer program (PC), assesses the curvatures of the vertebral column without applying harmful radiation. Spinal Mouse checks: spine alignment, measuring segmental and global angles in the sagittal and frontal planes; posture and spinal mobility; and spine functions and performance.</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">66</enrollment>
  <condition>Fibromyalgia</condition>
  <condition>Back Pain</condition>
  <arm_group>
    <arm_group_label>Dry Needling Therapy</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Dry Needly Therapy will be assesses in trigger points on latissimus dorsi, iliocostalis muscle, multifidus muscles, and quadratus lumbourum muscle.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Cross Tape Therapy</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Cross Tape is a grid-shaped bandage easy aplicacionen different parts of the body that regulates the tension.</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Dry Needling</intervention_name>
    <description>Dry needling is the use of either solid filiform needles or hollow-core hypodermic needles for therapy of muscle pain, sometimes also known as intramuscular stimulation (IMS). Although dry needling originally utilized only hypodermic needles due to the concern that solid filiform needles had neither the strength or tactile feedback that hypodermic needles provided and that the solid filiform needle could be deflected by &quot;dense contraction knots&quot;.</description>
    <arm_group_label>Dry Needling Therapy</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Cross Tape Therapy</intervention_name>
    <description>The tape consists of cross bands or strips mesh cross, nonelastic and without any medication, forming a grid-shaped patch. The cross tape will be applied on trigger points.</description>
    <arm_group_label>Cross Tape Therapy</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Fibromyalgia syndrome diagnosis.

          -  Aged from 18 to 65 years.

          -  No regular physical activity.

          -  Limitation of usual activities due to pain on at least 1 day in the previous 30 days.

          -  Agreement to attend evening therapy sessions.

        Exclusion Criteria:

          -  Severe physical disability.

          -  Comorbid conditions (eg, morbid obesity, inflammatory diseases, irritable bowel
             syndrome, interstitial cystitis).

          -  Uncontrolled endocrine disorders (eg, hyperthyroidism or hypothyroidism, diabetes).

          -  Malignancy.

          -  Psychiatric.

          -  Illnesses (eg, schizophrenia or substance abuse).

          -  Medication usage other than as-needed analgesics (excluding long-term narcotics).

          -  History of surgery.

          -  History of whiplash injury.

          -  Presence of a score &gt;9 points in the Beck Depression Inventory.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>65 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Univesity of Almería</name>
      <address>
        <city>Almería</city>
        <zip>04120</zip>
        <country>Spain</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Spain</country>
  </location_countries>
  <reference>
    <citation>Wolfe F, Clauw DJ, Fitzcharles MA, Goldenberg DL, Katz RS, Mease P, Russell AS, Russell IJ, Winfield JB, Yunus MB. The American College of Rheumatology preliminary diagnostic criteria for fibromyalgia and measurement of symptom severity. Arthritis Care Res (Hoboken). 2010 May;62(5):600-10. doi: 10.1002/acr.20140.</citation>
    <PMID>20461783</PMID>
  </reference>
  <reference>
    <citation>Wolfe F, Smythe HA, Yunus MB, Bennett RM, Bombardier C, Goldenberg DL, Tugwell P, Campbell SM, Abeles M, Clark P, et al. The American College of Rheumatology 1990 Criteria for the Classification of Fibromyalgia. Report of the Multicenter Criteria Committee. Arthritis Rheum. 1990 Feb;33(2):160-72.</citation>
    <PMID>2306288</PMID>
  </reference>
  <reference>
    <citation>Arnold LM, Clauw DJ, McCarberg BH; FibroCollaborative. Improving the recognition and diagnosis of fibromyalgia. Mayo Clin Proc. 2011 May;86(5):457-64. doi: 10.4065/mcp.2010.0738. Review.</citation>
    <PMID>21531887</PMID>
  </reference>
  <reference>
    <citation>Goldenberg DL. Fibromyalgia syndrome: an emerging but controversial condition. JAMA. 2014 Apr 16;311(15):1570. doi: 10.1001/jama.2013.279453.</citation>
    <PMID>24737378</PMID>
  </reference>
  <reference>
    <citation>Mas AJ, Carmona L, Valverde M, Ribas B; EPISER Study Group. Prevalence and impact of fibromyalgia on function and quality of life in individuals from the general population: results from a nationwide study in Spain. Clin Exp Rheumatol. 2008 Jul-Aug;26(4):519-26.</citation>
    <PMID>18799079</PMID>
  </reference>
  <reference>
    <citation>Branco JC, Bannwarth B, Failde I, Abello Carbonell J, Blotman F, Spaeth M, Saraiva F, Nacci F, Thomas E, Caubère JP, Le Lay K, Taieb C, Matucci-Cerinic M. Prevalence of fibromyalgia: a survey in five European countries. Semin Arthritis Rheum. 2010 Jun;39(6):448-53. doi: 10.1016/j.semarthrit.2008.12.003. Epub 2009 Feb 27.</citation>
    <PMID>19250656</PMID>
  </reference>
  <reference>
    <citation>Pastor Mira MÁ, Lledó Boyer A, López-Roig S, Pons Calatayud N, Martín-Aragón Gelabert M. [Predictors of healthcare resource use in fibromyalgia]. Psicothema. 2010 Nov;22(4):549-55. Spanish.</citation>
    <PMID>21044477</PMID>
  </reference>
  <reference>
    <citation>Castro-Sánchez AM, Matarán-Peñarrocha GA, Granero-Molina J, Aguilera-Manrique G, Quesada-Rubio JM, Moreno-Lorenzo C. Benefits of massage-myofascial release therapy on pain, anxiety, quality of sleep, depression, and quality of life in patients with fibromyalgia. Evid Based Complement Alternat Med. 2011;2011:561753. doi: 10.1155/2011/561753. Epub 2010 Dec 28.</citation>
    <PMID>21234327</PMID>
  </reference>
  <reference>
    <citation>Giamberardino MA, Affaitati G, Fabrizio A, Costantini R. Effects of treatment of myofascial trigger points on the pain of fibromyalgia. Curr Pain Headache Rep. 2011 Oct;15(5):393-9. doi: 10.1007/s11916-011-0205-3. Review.</citation>
    <PMID>21541831</PMID>
  </reference>
  <reference>
    <citation>Affaitati G, Costantini R, Fabrizio A, Lapenna D, Tafuri E, Giamberardino MA. Effects of treatment of peripheral pain generators in fibromyalgia patients. Eur J Pain. 2011 Jan;15(1):61-9. doi: 10.1016/j.ejpain.2010.09.002.</citation>
    <PMID>20889359</PMID>
  </reference>
  <reference>
    <citation>Alonso-Blanco C, Fernández-de-Las-Peñas C, de-la-Llave-Rincón AI, Zarco-Moreno P, Galán-Del-Río F, Svensson P. Characteristics of referred muscle pain to the head from active trigger points in women with myofascial temporomandibular pain and fibromyalgia syndrome. J Headache Pain. 2012 Nov;13(8):625-37. doi: 10.1007/s10194-012-0477-y. Epub 2012 Aug 31.</citation>
    <PMID>22935970</PMID>
  </reference>
  <reference>
    <citation>Alonso-Blanco C, Fernández-de-las-Peñas C, Morales-Cabezas M, Zarco-Moreno P, Ge HY, Florez-García M. Multiple active myofascial trigger points reproduce the overall spontaneous pain pattern in women with fibromyalgia and are related to widespread mechanical hypersensitivity. Clin J Pain. 2011 Jun;27(5):405-13. doi: 10.1097/AJP.0b013e318210110a.</citation>
    <PMID>21368661</PMID>
  </reference>
  <reference>
    <citation>Ge HY, Nie H, Madeleine P, Danneskiold-Samsøe B, Graven-Nielsen T, Arendt-Nielsen L. Contribution of the local and referred pain from active myofascial trigger points in fibromyalgia syndrome. Pain. 2009 Dec 15;147(1-3):233-40. doi: 10.1016/j.pain.2009.09.019. Epub 2009 Oct 9.</citation>
    <PMID>19819074</PMID>
  </reference>
  <reference>
    <citation>Ge HY, Wang Y, Danneskiold-Samsøe B, Graven-Nielsen T, Arendt-Nielsen L. The predetermined sites of examination for tender points in fibromyalgia syndrome are frequently associated with myofascial trigger points. J Pain. 2010 Jul;11(7):644-51. doi: 10.1016/j.jpain.2009.10.006. Epub 2009 Nov 14.</citation>
    <PMID>19914876</PMID>
  </reference>
  <reference>
    <citation>Ge HY. Prevalence of myofascial trigger points in fibromyalgia: the overlap of two common problems. Curr Pain Headache Rep. 2010 Oct;14(5):339-45. doi: 10.1007/s11916-010-0127-5. Review.</citation>
    <PMID>20607459</PMID>
  </reference>
  <reference>
    <citation>Hannuksela M, Väänänen A. The sauna, skin and skin diseases. Ann Clin Res. 1988;20(4):276-8.</citation>
    <PMID>3218900</PMID>
  </reference>
  <reference>
    <citation>Poulsen EU, Jørgensen JO, Madsen FF, Djurhuus JC. Cortical blood-flow in the porcine kidney. A radioactive microsphere study. Urol Res. 1988;16(5):385-7.</citation>
    <PMID>3201653</PMID>
  </reference>
  <reference>
    <citation>Kalichman L, Vulfsons S. Dry needling in the management of musculoskeletal pain. J Am Board Fam Med. 2010 Sep-Oct;23(5):640-6. doi: 10.3122/jabfm.2010.05.090296. Review.</citation>
    <PMID>20823359</PMID>
  </reference>
  <reference>
    <citation>Vulfsons S, Ratmansky M, Kalichman L. Trigger point needling: techniques and outcome. Curr Pain Headache Rep. 2012 Oct;16(5):407-12. doi: 10.1007/s11916-012-0279-6. Review.</citation>
    <PMID>22610507</PMID>
  </reference>
  <reference>
    <citation>Lim C, Park Y, Bae Y. The effect of the kinesio taping and spiral taping on menstrual pain and premenstrual syndrome. J Phys Ther Sci. 2013 Jul;25(7):761-4. doi: 10.1589/jpts.25.761. Epub 2013 Aug 20.</citation>
    <PMID>24259847</PMID>
  </reference>
  <reference>
    <citation>Fischer AA. Algometry in the daily practice of pain management. J Back Musculoskelet Rehabil. 1997 Jan 1;8(2):151-63. doi: 10.3233/BMR-1997-8209.</citation>
    <PMID>24572755</PMID>
  </reference>
  <reference>
    <citation>Guermazi M, Ghroubi S, Kassis M, Jaziri O, Keskes H, Kessomtini W, Ben Hammouda I, Elleuch MH. [Validity and reliability of Spinal Mouse to assess lumbar flexion]. Ann Readapt Med Phys. 2006 May;49(4):172-7. Epub 2006 Mar 20. French.</citation>
    <PMID>16630669</PMID>
  </reference>
  <reference>
    <citation>Ripani M, Di Cesare A, Giombini A, Agnello L, Fagnani F, Pigozzi F. Spinal curvature: comparison of frontal measurements with the Spinal Mouse and radiographic assessment. J Sports Med Phys Fitness. 2008 Dec;48(4):488-94.</citation>
    <PMID>18997653</PMID>
  </reference>
  <reference>
    <citation>Maarek A. Electro interstitial scan system: assessment of 10 years of research and development. Med Devices (Auckl). 2012;5:23-30. doi: 10.2147/MDER.S29319. Epub 2012 Mar 5.</citation>
    <PMID>23166454</PMID>
  </reference>
  <reference>
    <citation>Alexeev VG, Kuznecova LV. Bioimpedance in monitoring of effects of selective serotonin reuptake inhibitor treatment. Psychol Res Behav Manag. 2011;4:81-6. doi: 10.2147/PRBM.S22925. Epub 2011 Jun 30.</citation>
    <PMID>22114538</PMID>
  </reference>
  <reference>
    <citation>Lewis JE, Tannenbaum SL, Gao J, Melillo AB, Long EG, Alonso Y, Konefal J, Woolger JM, Leonard S, Singh PK, Chen L, Tiozzo E. Comparing the accuracy of ES-BC, EIS-GS, and ES Oxi on body composition, autonomic nervous system activity, and cardiac output to standardized assessments. Med Devices (Auckl). 2011;4:169-77. doi: 10.2147/MDER.S24291. Epub 2011 Sep 16.</citation>
    <PMID>22915943</PMID>
  </reference>
  <verification_date>January 2016</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>February 28, 2015</study_first_submitted>
  <study_first_submitted_qc>March 4, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">March 5, 2015</study_first_posted>
  <last_update_submitted>January 19, 2016</last_update_submitted>
  <last_update_submitted_qc>January 19, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">January 20, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Universidad de Almeria</investigator_affiliation>
    <investigator_full_name>Adelaida María Castro-Sánchez</investigator_full_name>
    <investigator_title>PhD (Lecturer)</investigator_title>
  </responsible_party>
  <keyword>Paraspinal Muscles</keyword>
  <keyword>Trigger Points</keyword>
  <keyword>Randomized Controlled Trial</keyword>
  <keyword>Mobility Limitation</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Back Pain</mesh_term>
    <mesh_term>Fibromyalgia</mesh_term>
    <mesh_term>Myofascial Pain Syndromes</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

